Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
2X Taq PCR Master Mix (with dye): Ready-to-Use PCR Reagen...
2026-01-30
The 2X Taq PCR Master Mix (with dye) offers a robust, ready-to-use solution for DNA amplification, integrating recombinant Taq DNA polymerase and direct gel-loading dye. This PCR reagent from APExBIO streamlines molecular workflows for genotyping, cloning, and sequence analysis, providing high efficiency and reproducibility.
-
Erastin and the Future of Ferroptosis: Strategic Insights...
2026-01-30
Erastin, a potent ferroptosis inducer, is transforming cancer biology by enabling precision targeting of iron-dependent, non-apoptotic cell death—especially in RAS/BRAF-mutant tumors. This thought-leadership article explores the mechanistic landscape, experimental best practices, translational applications, and emerging opportunities for Erastin in oncology. Building on foundational studies and advanced protocols, we examine how Erastin (from APExBIO) empowers translational researchers to unlock new therapeutic paradigms beyond apoptosis, and how combining ferroptosis inducers with immunotherapies could redefine cancer treatment.
-
Erastin: Precision Ferroptosis Inducer for Cancer Biology...
2026-01-29
Erastin empowers researchers to dissect iron-dependent, non-apoptotic cell death in RAS/BRAF-mutant tumors with unprecedented selectivity and reproducibility. This guide delivers actionable workflows, troubleshooting strategies, and advanced applications—anchored by recent mechanistic insights—to accelerate ferroptosis research and translational oncology breakthroughs.
-
EZ Cap™ Cas9 mRNA (m1Ψ): Advancing Precision Genome Editing
2026-01-29
EZ Cap™ Cas9 mRNA (m1Ψ) stands out as a next-generation capped Cas9 mRNA for genome editing, engineered for superior stability, immune evasion, and translational efficiency in mammalian cells. Its unique Cap1 and m1Ψ modifications empower researchers to achieve high-fidelity CRISPR-Cas9 outcomes, while streamlined workflows and mitigation strategies address persistent experimental challenges.
-
Heparin sodium (SKU A5066): Reliable Anticoagulant for Ce...
2026-01-28
This article provides an evidence-based, scenario-driven guide for using Heparin sodium (SKU A5066) in cell viability, proliferation, and cytotoxicity assays. Drawing on validated best practices and recent literature, it addresses common laboratory challenges and compares vendor reliability, highlighting the advantages of APExBIO’s Heparin sodium in reproducibility, sensitivity, and workflow efficiency.
-
Charting New Territory in Ferroptosis Research: Strategic...
2026-01-28
This thought-leadership article fuses mechanistic depth with translational strategy, guiding cancer researchers to harness Erastin—a precision ferroptosis inducer from APExBIO—for advanced studies in iron-dependent, non-apoptotic cell death. Through comparative evidence, workflow innovation, and future-focused recommendations, the article positions Erastin as a cornerstone for next-generation cancer therapy research, particularly in tumors with KRAS or BRAF mutations.
-
2X Taq PCR Master Mix (with dye): Enabling Precision Mole...
2026-01-27
Explore the scientific foundations and advanced applications of 2X Taq PCR Master Mix (with dye), a ready-to-use PCR reagent for genotyping, cloning, and TA cloning. This in-depth article uncovers its unique enzymatic features and workflow advantages for molecular biology research.
-
HyperTrap Heparin HP Column: Redefining High-Resolution P...
2026-01-27
Explore how the HyperTrap Heparin HP Column leverages advanced heparin affinity chromatography for precise purification of coagulation factors and growth factors. Discover its unique advantages and new scientific applications in dissecting cancer stemness mechanisms, setting it apart from previous research.
-
Erastin: Precision Ferroptosis Inducer for Cancer Biology...
2026-01-26
Erastin empowers researchers to dissect iron-dependent, non-apoptotic cell death in RAS/BRAF-mutant tumors with unrivaled specificity. Leveraging APExBIO’s validated Erastin streamlines ferroptosis research workflows, enhances oxidative stress assays, and unlocks advanced strategies in cancer therapy targeting ferroptosis.
-
Erastin: A Benchmark Ferroptosis Inducer for Cancer Biolo...
2026-01-26
Erastin is a validated ferroptosis inducer that selectively triggers iron-dependent non-apoptotic cell death in RAS/BRAF-mutant tumor cells. As a core tool in cancer biology and oxidative stress research, Erastin enables precise disruption of redox homeostasis and supports translational oncology workflows.
-
Erastin: Precision Ferroptosis Inducer for Cancer Biology...
2026-01-25
Erastin is a state-of-the-art ferroptosis inducer optimized for dissecting iron-dependent, non-apoptotic cell death in RAS/BRAF-mutant tumors. Leveraging APExBIO's validated compound unlocks advanced modeling of oxidative stress and translational oncology workflows. Discover hands-on protocols, troubleshooting tips, and experimental innovations that set Erastin apart in cancer biology research.
-
Erastin and the Future of Ferroptosis Research: Translati...
2026-01-24
This thought-leadership article explores Erastin's mechanistic role as a ferroptosis inducer, its experimental and translational impact for cancer researchers, and actionable strategies to harness its specificity in RAS/RAF-mutant tumor models. Drawing on recent evidence—including its capacity to overcome chemoresistance—we contextualize Erastin (SKU B1524) within the competitive landscape and map a forward-looking vision for precision oncology.
-
2X Taq PCR Master Mix (with dye): Precision DNA Amplifica...
2026-01-23
Explore how the 2X Taq PCR Master Mix (with dye) accelerates high-fidelity DNA amplification in cancer genomics and DNA repair research. Discover the unique molecular advantages and workflow efficiencies of this ready-to-use PCR reagent for genotyping and cloning.
-
2X Taq PCR Master Mix: Streamlined PCR for Genotyping & C...
2026-01-23
Unlock robust, reproducible DNA amplification with the 2X Taq PCR Master Mix (with dye). This ready-to-use PCR master mix accelerates workflows for genotyping, TA cloning, and direct gel analysis, empowering research in neurobiology and beyond. Discover advanced protocols, troubleshooting insights, and how this master mix outperforms traditional PCR reagents.
-
Reliable PCR for Cell Assays: Scenario-Based Insights wit...
2026-01-22
This article explores five real-world laboratory scenarios where 2X Taq PCR Master Mix (with dye) (SKU K1034) addresses key challenges in cell viability, proliferation, and cytotoxicity assay workflows. The piece offers evidence-based best practices, quantitative context, and actionable guidance for biomedical researchers and technicians seeking reproducible and efficient PCR amplification. Learn how SKU K1034 streamlines DNA analysis from experimental design to data interpretation.
16680 records 17/1112 page Previous Next First page 上5页 1617181920 下5页 Last page